Keyphrases
Randomized Controlled Trial
100%
Asthmatic
100%
Small Airways
100%
Inhalation Therapy
100%
Olodaterol
100%
Inhaled Corticosteroids
71%
Long-acting beta-agonists
42%
Impulse Oscillometry
42%
Forced Expiratory Volume in 1 Second (FEV1)
28%
FEF25-75
28%
Long-acting muscarinic Antagonist
28%
Resonant Frequency
14%
Smokers
14%
Current Smokers
14%
Spirometry
14%
Induced Resistance
14%
Asthmatic Inflammation
14%
Asthma Patients
14%
Peripheral Airway Resistance
14%
Washout Period
14%
Tiotropium
14%
Airway Resistance
14%
Peripheral Lung
14%
Small Airway Dysfunction
14%
Randomized Crossover Design
14%
Reactance Area
14%
Pack-years
14%
Bad Controls
14%
Medicine and Dentistry
Randomized Controlled Trial
100%
Asthma
100%
Olodaterol
100%
Oscillometry
42%
Beta Adrenergic Receptor Stimulating Agent
42%
Airway Resistance
28%
Muscarinic Antagonist
28%
Smoke
14%
Spirometry
14%
Lung
14%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Asthma
100%
Olodaterol
100%
Beta Adrenergic Receptor Stimulating Agent
42%
Muscarinic Receptor Blocking Agent
28%
Inflammation
14%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Olodaterol
100%
Beta-Adrenergic Agonist
42%
Muscarinic Antagonist
28%